Indexé dans
  • Base de données des revues académiques
  • Ouvrir la porte J
  • Genamics JournalSeek
  • JournalTOCs
  • Infrastructure nationale des connaissances en Chine (CNKI)
  • Scimago
  • Répertoire des périodiques d'Ulrich
  • RechercheRef
  • Université Hamdard
  • EBSCO AZ
  • OCLC - WorldCat
  • Publions
  • MIAR
  • Commission des bourses universitaires
  • Fondation genevoise pour la formation et la recherche médicales
  • Pub européen
  • Google Scholar
Partager cette page

Abstrait

Impact of Immunologic Discoveries on the Vaccine

Zelalem Kiros Bitsue*

The spike glycoprotein (S1) interacts with host cell epithelial Angiotensin-Converting Enzyme-2 (ACE-2) receptors. The nano-luciferase-based assay shows that the virus’s 1 protein has a strong binding affinity with the ACE-2 receptors. Reports illustrate the S-protein antigenic epitope of SARS-CoV-2 binds with the TLR4/ MD-2 complex by strong molecular bonding interactions. The pool of miRNA based studies shows that TMPRSS2 acts as promising regulators for the SARS-CoV-2 entry checkpoint. Recent report stated that the AT1R phosphorylates JAK2 in the lung cells, which activates STAT-3 transduction to the nucleus.

Not only I discovered vaccine AZEE CRA 01, immune cell principles and methods of vaccination but also B cells have two components. B cells synthesis both MHC I, and MHC II. CD4 interacts with MQ, MHC II, CD8 Interacts with DC, MHC I, and B cells interacts with both MHC I, and MHC II, and Th2 and Tc1 (CD4 and CD8).

In these original articles I report the pandemics and immune cells, immunologic clearance and immune mechanisms, the discovery process: innovation and immunology, zelalem kiros bitsue and his vaccine discoveries, zelalem kiros bitsue and his immunologic discoveries, vaccine discovered and mechanisms of action 1of 2.